Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nzeno Limited manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The data shows 1 pending office action for the company. This workload is distributed among 1 distinct examiner and 1 distinct art unit, which points to a very specific and singular focus for the company's current patent prosecution activity. Such a concentrated profile often indicates that the company is pursuing a key piece of intellectual property within a specialized technical domain.
WILSON, MICHAEL C is the busiest examiner for Nzeno Limited, with 1 busiest examiner pending office action. This figure represents the entirety of the company's 1 pending office action. Because there is only 1 distinct examiner and 1 distinct art unit involved, the company's current interactions with the patent office are centralized. This structure allows for a direct focus on the requirements of a 1 examiner. The outcome of the company's current filings will be determined by the specific examination criteria applied by this 1 individual within the biotechnology sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILSON, MICHAEL C | 1 | 41.5% | +17.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17632376 | DONOR PIGS FOR XENOTRANSPLANTATION | WILSON, MICHAEL C | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17632376 | DONOR PIGS FOR XENOTRANSPLANTATION | WILSON, MICHAEL C | 1638 | §103 | Final Rejection | — | Pending | Feb 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNzeno Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Michael C Wilson has the most, with 1 of Nzeno Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
